Hallo! Tracked shipping to Austria with Delivery Duty Paid for just €3.99  

Ship to
Austria
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Methodologies in Biosimilar Product Development (Chapman & Hall
Type
Physical Book
Illustrated by
Publisher
Author
Year
2021
Language
English
Pages
380
Format
Hardcover
Dimensions
23.4 x 15.6 x 2.2 cm
Weight
0.73 kg.
ISBN13
9780367896348
Edition No.
1
Categories

Methodologies in Biosimilar Product Development (Chapman & Hall

Sang Joon Lee (Illustrated by) · Shein-Chung Chow (Illustrated by) · CRC Press · Hardcover

Methodologies in Biosimilar Product Development (Chapman & Hall - Lee, Sang Joon ; Chow, Shein-Chung

Cheaper New Book Imported to Austria
Delivery: 15 Sep - 22 Sep Shipping: 19 to 23 business days.
229,71 €
Faster New Book Imported to Austria
Delivery: 25 Aug - 27 Aug Shipping: 5 to 6 business days.
411,53 €
Import costs and 10% VAT included in the price ✅
229,71 €

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Methodologies in Biosimilar Product Development (Chapman & Hall "

Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the mix-up use of interval hypotheses testing (i.e., the use of TOST) and confidence interval approach, a risk/benefit assessment for non-inferiority/similarity margin, PK/PD bridging studies with multiple references, the detection of possible reference product change over time, design and analysis of biosimilar switching studies, the assessment of sensitivity index for assessment of extrapolation across indications without collecting data from those indications not under study, and the feasibility and validation of non-medical switch post-approval. Key Features: Reviews withdrawn draft guidance on analytical similarity assessment. Evaluates various methods for analytical similarity evaluation based on FDA's current guidelines. Provides a general approach for the use of n-of-1 trial design for assessment of interchangeability. Discusses the feasibility and validity of the non-medical switch studies. Provides innovative thinking for detection of possible reference product change over time. This book embraces innovative thinking of design and analysis for biosimilar studies, which are required for review and approval of biosimilar regulatory submissions.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews